Nanoparticle-driven reactive oxygen species therapy: A new frontier in osteosarcoma treatment

Area of Science:

• Biomedical Engineering
• Oncology
• Nanotechnology

Background:

• Reactive oxygen species (ROS) are crucial for osteosarcoma (OS) therapy, inducing cell death.
• OS cells have higher ROS levels, creating a therapeutic window, but their antioxidant defenses limit conventional treatments.
• Nanoparticle-based strategies are emerging to enhance ROS generation for improved OS therapy.

Purpose of the Study:

• To systematically review and classify ROS-upregulating nanoparticles for OS treatment.
• To discuss the therapeutic potential and mechanisms of action of these nanoplatforms.
• To identify challenges and future directions in developing nanomaterials for OS therapy.

Main Methods:

• Literature review and systematic classification of ROS-generating nanoparticles.
• Analysis of nanoparticle mechanisms, therapeutic efficacy, and challenges.
• Discussion of future research and development in nanomedicine for OS.

Main Results:

• ROS-generating nanoparticles offer a promising strategy to overcome OS cell antioxidant defenses.
• Classification based on mechanisms reveals diverse approaches to ROS modulation.
• Significant progress has been made, but a comprehensive framework for nanoplatform design is still needed.

Conclusions:

• Nanoparticle-based ROS upregulation is a viable strategy for selective osteosarcoma therapy.
• Further research is needed to optimize nanoplatform design and overcome clinical limitations.
• This review provides a framework to guide the development of next-generation nanomaterials for osteosarcoma treatment.